1LY3
ANALYSIS OF QUINAZOLINE AND PYRIDOPYRIMIDINE N9-C10 REVERSED BRIDGE ANTIFOLATES IN COMPLEX WITH NADP+ AND PNEUMOCYSTIS CARINII DIHYDROFOLATE REDUCTASE
Summary for 1LY3
Entry DOI | 10.2210/pdb1ly3/pdb |
Related | 1LY4 |
Descriptor | DIHYDROFOLATE REDUCTASE, NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE, 2,4-DIAMINO-6-[N-(2',5'-DIMETHOXYBENZYL)-N-METHYLAMINO]QUINAZOLINE, ... (4 entities in total) |
Functional Keywords | pcdhfr reversed bridge antifolates, oxidoreductase |
Biological source | Pneumocystis carinii |
Total number of polymer chains | 1 |
Total formula weight | 25001.33 |
Authors | Cody, V.,Galitsky, N.,Luft, J.R.,Pangborn, W.,Queener, S.F.,Gangjee, A. (deposition date: 2002-06-06, release date: 2002-08-28, Last modification date: 2024-02-14) |
Primary citation | Cody, V.,Galitsky, N.,Luft, J.R.,Pangborn, W.,Queener, S.F.,Gangjee, A. Analysis of quinazoline and pyrido[2,3-d]pyrimidine N9-C10 reversed-bridge antifolates in complex with NADP+ and Pneumocystis carinii dihydrofolate reductase. Acta Crystallogr.,Sect.D, 58:1393-1399, 2002 Cited by PubMed: 12198294DOI: 10.1107/S0907444902010442 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.9 Å) |
Structure validation
Download full validation report